COVID-19 Respiratory Infection
110
8
13
54
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Research Maturity
54 completed trials (49% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.7%
3 terminated out of 110 trials
94.7%
+8.2% vs benchmark
10%
11 trials in Phase 3/4
6%
3 of 54 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 54 completed trials
Clinical Trials (110)
Pancoronavirus Vaccine Study in Healthy Adults
Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
Preventing Respiratory Viral Illness Invisibly
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies
Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine
Lung Structure-Function In SurVivors of Mild and SEvere COVID-19 Infection: 129Xe MRI
Xanthohumol as an Adjuvant Therapy in Critically Ill COVID-19 Patients
Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit
Posture and Pain Measurements in Post-COVID-19
Pain, Physical Activity, Posture and Quality of Life in Post-COVID-19 Individuals With Idiopathic Scoliosis
Chest Mobility, Strength, Physical Activity and Quality of Life in Parkinson's Patients With Post-COVID-19
Exercise and COVID-19 Viral T-cell Immunity
Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients
Respiratory Virus Metagenomics After COVID-19
Universal Anti-Viral Vaccine for Healthy Elderly Adults
Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness
Cromolyn Sodium for Treatment of COVID-19 Pneumonia
Cardiopulmonary Rehabilitation in Long COVID-19 Patients With Persistent Breathlessness and Fatigue
Follow-up of Covid-19 Long Term Sequelae